![Rocio Hoyos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rocio Martin Hoyos currently works at Atrium Therapeutics, Inc., as Chief Strategy Officer.
Ms. Hoyos also formerly worked at Astellas Gene Therapies, Inc., as Vice President-Global & US Marketing and Kronos Bio, Inc., as Senior Vice President-Commercial Strategy from 2021 to 2024.
Ms. Hoyos received her Masters Business Admin degree from the University of Navarra and graduate degree from Universidad Autónoma de Madrid.
| Sociétés | Poste | Début |
|---|
| Sociétés | Poste | Fin |
|---|---|---|
| KRONOS BIO, INC. | Corporate Officer/Principal | 01/04/2024 |
| AUDENTES THERAPEUTICS, INC. | Sales & Marketing | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 4 |
|---|---|
University of Navarra
 University of Navarra Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universidad Autónoma de Madrid
 Universidad Autónoma de Madrid Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes gene therapy products for patients with serious rare diseases | Health Technology |
Kronos Bio, Inc.
 Kronos Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel cancer therapeutics | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
